Medtronic (NYSE:MDT) has plans to submit its MiniMed 780G for an expanded indication from the FDA for type 2 diabetes in the near future.

Revenue increased 5.3% year over year, as reported, and 5% on an organic basis. Also Read: Medtronic Recalls MiniMed Pump Due ...

The CONTOUR Link wirelessly transmits blood glucose test results to compatible Medtronic insulin pumps and continuous glucose monitoring systems making insulin dosing easier than ever.

With a new smartphone app clearance from the FDA, Medtronic said it has all the pieces necessary to deliver a complete ...

The InPen app paves the way for the launch of the company’s “Smart MDI” system combining a smart insulin pen that tracks ...

The clearance allows the system to offer personalised insights for individuals managing diabetes through MDI therapies.

Also Read: Medtronic Recalls MiniMed Pump Due To Battery Life Concerns Cardiovascular segment revenue reached $3.102 billion, up 6.1% year over year as reported, and increased 5.6% organically ...

Medtronic beat quarterly expectations Tuesday, but Medtronic stock dipped near a sell zone in early trading. Medtronic (MDT) ...